JP2673992B2 - Food composition - Google Patents

Food composition

Info

Publication number
JP2673992B2
JP2673992B2 JP2125544A JP12554490A JP2673992B2 JP 2673992 B2 JP2673992 B2 JP 2673992B2 JP 2125544 A JP2125544 A JP 2125544A JP 12554490 A JP12554490 A JP 12554490A JP 2673992 B2 JP2673992 B2 JP 2673992B2
Authority
JP
Japan
Prior art keywords
calcium
glucose
sodium alginate
dietary fiber
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2125544A
Other languages
Japanese (ja)
Other versions
JPH0423968A (en
Inventor
篤胤 太田
愛美 大橋
昌彦 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP2125544A priority Critical patent/JP2673992B2/en
Publication of JPH0423968A publication Critical patent/JPH0423968A/en
Application granted granted Critical
Publication of JP2673992B2 publication Critical patent/JP2673992B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、食品用組成物に関する。本発明の食品用組
成物は、空腹感を軽減し、摂食量を減少させることを目
的とするもので、たとえば肥満の予防および治療時の減
食療法などのほか、飲食後栄養素の吸収を遅延させて血
液成分の急激な変化を避け、結果として耐糖能を改善し
インスリンの分泌を抑制する目的で糖尿病患者など耐糖
能の低下している物および耐糖能の低下を予防したい者
の食事に配合し使用される。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a food composition. The food composition of the present invention is intended to reduce the feeling of hunger and to reduce the amount of food intake, for example, in addition to anti-medication therapy during obesity prevention and treatment, delay absorption of nutrients after eating and drinking. For the purpose of avoiding sudden changes in blood components and consequently improving glucose tolerance and suppressing insulin secretion, it is added to the diet of people with reduced glucose tolerance such as diabetics and those who want to prevent glucose tolerance. used.

〔従来の技術および発明が解決しようとする課題〕[Problems to be solved by conventional technology and invention]

飽食の時代と言われる今日、肥満症の増加は重大な社
会問題となりつつある。疫学的な調査からも肥満者で
は、糖尿病、高血圧、心臓病などの成人病の発生率が高
いことなども報告されている。肥満症の大部分は摂取カ
ロリーの過剰に起因している。従って、その予防や治療
の基本は、摂取カロリーを低減すること、すなわち減食
療法を実施することである。減食療法の実施における最
大の障害は強い空腹管のために継続が困難となることで
ある。空腹感を形成する要因としては、血糖値の低下、
血中遊離脂肪酸やケトン体の上昇などがある。また、胃
に対する機械的親展刺激が、空腹感を軽減することも古
くから経験的に知られている。これを利用して空腹感を
軽減する目的でカロリーが低く、かさの多い食物繊維を
食品に配合するなどの工夫がなされてきた。食物繊維に
よって持続的に空腹感を軽減するためには、食物繊維が
長時間胃内に滞留することが必要である。食物繊維の胃
内滞留時間は、その粘度と相関が高いと言われている。
従って、空腹感の軽減効果を高めるためには、より高粘
度の食品を摂取する必要があり、嗜好上の困難があっ
た。
In today's era of satiety, the increase in obesity is becoming a serious social problem. Epidemiological studies have also reported that obese people have a high incidence of adult diseases such as diabetes, high blood pressure, and heart disease. Most obesity results from excessive calories. Therefore, the basis of its prevention and treatment is to reduce the calorie intake, that is, to carry out dietary therapy. The biggest obstacle in the implementation of anti-dietary therapy is the difficulty of continuation due to the strong hunger tube. Factors that cause a feeling of hunger include a decrease in blood sugar level,
There are elevated levels of free fatty acids and ketone bodies in the blood. It has also been empirically known for a long time that mechanical confidential stimulation of the stomach reduces the feeling of hunger. Utilizing this, for the purpose of reducing the feeling of hunger, various measures have been taken such as adding low bulk calorie and bulky dietary fiber to food. In order for dietary fiber to continuously reduce the feeling of hunger, it is necessary for the dietary fiber to stay in the stomach for a long time. It is said that the residence time of dietary fiber in the stomach is highly correlated with its viscosity.
Therefore, in order to enhance the effect of reducing the feeling of hunger, it is necessary to ingest a food of higher viscosity, which is difficult to taste.

また、昨今の研究から食物繊維には脂質代謝改善作用
や耐糖能改善作用があることも報告されている。耐糖能
改善作用もまた空腹感の軽減作用と同様、粘度と相関が
高いと言われている。一方、食物繊維の大量摂取には、
ミネラルやビタミンなどの微量栄養素の吸収阻害などの
負の効果が懸念されている。従って、いかに少量の食物
繊維で空腹感の軽減や耐糖能改善作用を発現させるかが
最大の課題である。このような考えに基づいた提案がな
されている(特開昭63−185339)。この発明は、カゼイ
ンとカラギナンなどの蛋白と反応性を有する水溶性食物
繊維を組合せ、この組成物がpHの低下に伴いゲルを形成
する特性を利用し、胃内でゲルを形成させようとするも
のである。しかし、この組成物は粘度が温度に依存性の
高い食物繊維を用いているため、低温では粘度が高くな
り、食感が著しく損なわれる。そのため、この組成物は
スープのごとき高温で摂取される食品に用途が限定され
ていた。また、カゼインが変性するような高温などの条
件下でこの組成物を含有する食品を加工することはでき
なかった。
Further, recent studies have also reported that dietary fiber has a lipid metabolism improving action and a glucose tolerance improving action. It is said that the glucose tolerance-improving action also has a high correlation with the viscosity, like the hunger reducing action. On the other hand, for a large intake of dietary fiber,
There are concerns about negative effects such as absorption inhibition of micronutrients such as minerals and vitamins. Therefore, how to reduce the feeling of hunger and improve glucose tolerance with a small amount of dietary fiber is the most important issue. A proposal based on such an idea has been made (JP-A-63-185339). This invention combines water-soluble dietary fiber that is reactive with proteins such as casein and carrageenan, and takes advantage of the fact that this composition forms a gel with a decrease in pH, and attempts to form a gel in the stomach. It is a thing. However, since this composition uses dietary fiber whose viscosity is highly temperature-dependent, the viscosity becomes high at low temperatures and the texture is significantly impaired. Therefore, the composition is limited in use to foods that are ingested at high temperatures, such as soups. Also, it has not been possible to process foods containing this composition under conditions such as high temperatures where casein is modified.

〔課題を解決するための手段〕[Means for solving the problem]

本発明の第1の目的は、胃内滞留時間が著しく長く、
低温でも食感が損なわれることなく、かつ嗜好性に優
れ、しかも摂取の不足が指摘されている食物繊維とカル
シウムを含有する肥満の治療または予防に使用される食
品用組成物を提供することにある。
The first object of the present invention is to significantly increase the residence time in the stomach,
To provide a food composition that is used for the treatment or prevention of obesity containing dietary fiber and calcium, which is not affected by the texture even at low temperatures, has excellent palatability, and is pointed out to be insufficiently taken. is there.

本発明の第2の目的は、耐糖能が低下した者の血糖値
の急激な上昇を抑えインスリンの過剰分泌を抑制させる
食品用組成物を提供することにある。
It is a second object of the present invention to provide a food composition that suppresses a rapid rise in blood glucose level of a person with impaired glucose tolerance and suppresses excessive secretion of insulin.

かかる目的は下記の構成を有する本発明の食品用組成
物によって達成される。
This object is achieved by the food composition of the present invention having the following constitution.

(a)アルギン酸またはその塩と、(b)炭酸カルシ
ウム,第3燐酸カルシウム,卵殻カルシウム,牛骨カル
シウムおよび魚骨カルシウムの中から選ばれた1種また
は2種以上のカルシウム化合物を含有する組成物からな
り、(a)アルギン酸またはその塩と(b)カルシウム
化合物中のカルシウムとの重量比が1:0.5〜1:2であるこ
とを特徴とする食品用組成物。
A composition containing (a) alginic acid or a salt thereof and (b) one or more calcium compounds selected from calcium carbonate, tribasic calcium phosphate, egg shell calcium, bovine bone calcium and fish bone calcium. 1. A food grade composition comprising: (a) alginic acid or a salt thereof and (b) a calcium compound in a weight ratio of 1: 0.5 to 1: 2.

以下に本発明の食品組成物について詳しく説明する。 The food composition of the present invention will be described in detail below.

本発明に用いるアルギン酸またはその塩、例えばアル
ギン酸ナトリウム,アルギン酸カリウムなどは水溶性食
物繊維である。また、カルシウム化合物としては炭酸カ
ルシウム,第3燐酸カルシウム,卵殻カルシウム,牛骨
カルシウム,魚骨カルシウムなどが好ましいものであ
り、これらを単独で、もしくは2種以上を組合せて用い
る。これらのカルシウム化合物は中性領域では不溶性も
しくはほとんど溶解せず、従って、このような条件下で
該水溶性食物繊維と混合しても、この時点ではゲル化し
ない。さらに、水溶性食物繊維とカルシウム化合物中の
カルシウムとの重量比は1:0.5〜1:2である。水溶性食物
繊維に対するカルシウム化合物中のカルシウムの割合が
少なすぎると、胃酸によりカルシウム化合物が全て溶解
しても十分なゲル化は起こない。一方、カルシウム化合
物中のカルシウムの水溶性食物繊維に対する重量が多す
ぎると、カルシウム化合物のざらつき感が生じ、嗜好性
が低下する。
Alginic acid or a salt thereof used in the present invention, such as sodium alginate and potassium alginate, is a water-soluble dietary fiber. As the calcium compound, calcium carbonate, tricalcium phosphate, egg shell calcium, bovine bone calcium, fish bone calcium and the like are preferable, and these are used alone or in combination of two or more kinds. These calcium compounds are insoluble or almost insoluble in the neutral region and, therefore, do not gel at this point when mixed with the water-soluble dietary fiber under such conditions. Further, the weight ratio of water-soluble dietary fiber to calcium in the calcium compound is 1: 0.5 to 1: 2. If the ratio of calcium in the calcium compound to the water-soluble dietary fiber is too low, sufficient gelation does not occur even if the calcium compound is completely dissolved by the gastric acid. On the other hand, if the weight of calcium in the calcium compound is too large with respect to the water-soluble dietary fiber, the calcium compound will have a rough feeling and the palatability will decrease.

また、本発明の食品用組成物は呈味性が低いので、本
発明の目的を逸脱しない範囲でいかなる食品にも配合す
ることができる。
Moreover, since the food composition of the present invention has a low taste, it can be incorporated into any food within the range not departing from the object of the present invention.

〔実施例〕〔Example〕

次に、本発明の試験例および実施例を示すが、本発明
はこれらにより制限されるものではない。
Next, test examples and examples of the present invention will be shown, but the present invention is not limited thereto.

試験例1 種々の水溶性食物繊維と種々のカルシウム化合物との
混合物の中性領域および酸性領域でのゲル形成について
比較した。すなわち、アルギン酸ナトリウム,カラギー
ナン,ペクチン,アラビアガム,グアガム,カルボキシ
メチルセルロースおよびキサンタンガムについてそれぞ
れ500mgを計り取り蒸留水50mlに溶解した後、1NのNaOH
溶液でpHを7.0とし、さらに蒸留水を加え100mlとした。
この溶液を5mlづつ試験管に分取した。この分取した溶
液に塩化カルシウム,炭酸カルシウム,クエン酸カルシ
ウム,燐酸水素カルシウム,乳酸カルシウム,第3燐酸
カルシウム,卵殻カルシウム,牛骨カルシウムおよび魚
骨カルシウムをカルシウムとして25mgとなるよう添加
し、溶解ないし懸濁した。この時の溶液の性状を観察
し、その結果を表1に示す。さらに、この溶液に1/10N
の塩酸200μを加えて撹拌し、その性状を観察した。
結果を表2に示す。表1および表2に示すごとく、pH7.
0では溶液の性状に変化がなく、塩酸添加時にゲルを形
成する組合せは、アルギン酸ナトリウムまたはジェラン
ガムと炭酸カルシウム,第3燐酸カルシウム,卵殻カル
シウム,牛骨カルシウムまたは魚骨カルシウムの組合せ
のみであった。なお、ペクチンもゲルを形成するが、こ
のゲルは弱いものであった。また、第3燐酸カルシウム
は牛骨カルシウムと、炭酸カルシウムは卵殻カルシウム
とほぼ同等の組成を有し、本試験例においてもゲル形成
に関して同様の作用を示すことから、以下の実施例では
水溶性食物繊維としてはアルギン酸ナトリウムおよびジ
ェランガムを、カルシウム化合物としては炭酸カルシウ
ムおよび第3燐酸カルシウムを使用することとした。
Test Example 1 Mixing of various water-soluble dietary fibers and various calcium compounds was compared for gel formation in a neutral region and an acidic region. That is, 500 mg each of sodium alginate, carrageenan, pectin, gum arabic, guar gum, carboxymethyl cellulose and xanthan gum was measured and dissolved in 50 ml of distilled water, and then 1N NaOH was added.
The pH of the solution was adjusted to 7.0, and distilled water was added to 100 ml.
5 ml of this solution was dispensed into test tubes. Calcium chloride, calcium carbonate, calcium citrate, calcium hydrogen phosphate, calcium lactate, tribasic calcium phosphate, egg shell calcium, beef bone calcium and fish bone calcium were added to this separated solution so as to give a calcium content of 25 mg. Suspended. The properties of the solution at this time were observed, and the results are shown in Table 1. Furthermore, 1 / 10N in this solution
200 μL of hydrochloric acid was added and stirred, and the properties were observed.
Table 2 shows the results. As shown in Table 1 and Table 2, pH of 7.
At 0, there was no change in the properties of the solution, and the only combination that formed a gel when hydrochloric acid was added was a combination of sodium alginate or gellan gum with calcium carbonate, calcium triphosphate, egg shell calcium, beef bone calcium or fish bone calcium. Pectin also formed a gel, but this gel was weak. Further, since tribasic calcium phosphate has a composition almost equal to that of bovine bone calcium and calcium carbonate has a composition similar to that of egg shell calcium, and also in this test example, the same action regarding gel formation is exhibited, the following examples show that water-soluble foods are used. Sodium alginate and gellan gum were used as fibers, and calcium carbonate and tricalcium phosphate were used as calcium compounds.

試験例2 アルギン酸ナトリウムまたはジェランガムと炭酸カル
シウムの混合物と先行技術であるカラギナンとカゼイン
ナトリウムの混合物について粘度の温度依存性を比較し
た。すなわち、50ml容のビーカーを3個用意し、その1
つにはアルギン酸ナトリウム250mgと炭酸カルシウム250
mgを、2個目にはジェランガム250mgと炭酸カルシウム2
50mgを、残る1つにはカラギナン250mgとカゼインナト
リウム125mgをそれぞれ計り取り蒸留水を加え、60℃の
恒温槽内で加温しながら溶解し50mlとした。この3種類
の溶液について60℃,50℃,40℃,30℃,25℃(室温),20
℃,10℃および4℃(冷蔵温度)の各温度における粘度
を測定した。粘度の測定はB型回転粘度計(東京計器製
造所(株)製)を用いて行った。結果は第1図に示すご
とく、アルギン酸ナトリウムと炭酸カルシウムの溶液で
は温度低下に伴う粘度の上昇はほとんど見られず、摂取
も容易であった。
Test Example 2 The temperature dependence of viscosity was compared between a mixture of sodium alginate or gellan gum and calcium carbonate and a mixture of prior art carrageenan and sodium caseinate. In other words, prepare three beakers with a capacity of 50 ml.
250 mg sodium alginate and 250 calcium carbonate
250 mg gellan gum and calcium carbonate 2 for the second
To the remaining one, 250 mg of carrageenan and 125 mg of sodium caseinate were weighed and distilled water was added, and the mixture was dissolved in a constant temperature bath at 60 ° C while heating to make 50 ml. About these 3 kinds of solutions, 60 ℃, 50 ℃, 40 ℃, 30 ℃, 25 ℃ (room temperature), 20 ℃
The viscosity was measured at each temperature of ° C, 10 ° C and 4 ° C (refrigerating temperature). The viscosity was measured using a B-type rotational viscometer (manufactured by Tokyo Keiki Seisakusho Co., Ltd.). As shown in Fig. 1, the results showed that the solution of sodium alginate and calcium carbonate showed almost no increase in viscosity with decreasing temperature and was easy to take.

実施例1 100ml容のメスフラスコを3本用意し、1本目にはア
ルギン酸ナトリウム500mg,炭酸カルシウム500mgおよび
グルコース10gをメスフラスコに取り蒸留水を加えて溶
解し、100mlとした。2本目には、アルギン酸ナトリウ
ム500mgおよびグルコース10gをメスフラスコに取り蒸留
水を加えて溶解し、100mlとした。3本目には、グルコ
ース10gをメスフラスコに取り蒸留水を加えて溶解し、1
00mlとした。この3種類の試料の胃内滞留時間を比較す
べくラットに投与した。ラットはSD系雄性、体重約200g
のものを1群6個体とし、計18個を用いた。
Example 1 Three 100-ml volumetric flasks were prepared. First, 500 mg of sodium alginate, 500 mg of calcium carbonate and 10 g of glucose were placed in a volumetric flask and dissolved in distilled water to make 100 ml. For the second bottle, 500 mg of sodium alginate and 10 g of glucose were placed in a volumetric flask and distilled water was added to dissolve the mixture to make 100 ml. For the third, take 10 g of glucose into a volumetric flask and add distilled water to dissolve it.
00 ml. Rats were administered to compare the gastric residence times of these three samples. Rats are SD males, weighing approximately 200g
One group consisted of 6 individuals, and a total of 18 were used.

まず、ラットを24時間絶食させ、上記3種類の試料を
体重100g当り1mlの割合で胃ゾンデにて強制投与した。
投与30分後、断頭屠殺し、腹部を切開して胃の幽門部お
よび食道をクレンメで閉塞後、胃を摘出した。摘出した
胃の内容物を最終量が10mlとなるように蒸留水で洗い込
み試験管に取った。この溶液を3000rpmで10分間遠心分
離し、得られた上清をムタロターゼ・GOD法でグルコー
ス量を測定し、各試料の胃内残存率を求めた。結果を第
2図に示す。第2図に示されるごとく、アルギン酸ナト
リウム0.5%,炭酸カルシウム0.5%およびグルコース10
%を投与した群は、他の2群に比して有意に高い残存率
を示した。また、アルギン酸ナトリウム0.5%,炭酸カ
ルシウム0.5%およびグルコース10%を投与した群は、
投与した試料が胃内で透明なゲルを形成していた。
First, rats were fasted for 24 hours, and the above-mentioned three kinds of samples were forcibly administered by a gastric sonde at a rate of 1 ml per 100 g of body weight.
Thirty minutes after the administration, the animals were sacrificed by decapitation, the abdomen was incised, the pyloric region of the stomach and the esophagus were occluded with a clamp, and the stomach was extracted. The content of the excised stomach was washed with distilled water so that the final amount was 10 ml, and then taken into a test tube. This solution was centrifuged at 3000 rpm for 10 minutes, and the resulting supernatant was measured for glucose by the mutarotase / GOD method to determine the gastric residual rate of each sample. The results are shown in FIG. As shown in FIG. 2, sodium alginate 0.5%, calcium carbonate 0.5% and glucose 10%.
The group to which% was administered showed a significantly higher survival rate than the other two groups. In addition, the group administered with sodium alginate 0.5%, calcium carbonate 0.5% and glucose 10%,
The administered sample formed a clear gel in the stomach.

実施例2 100ml容のメスフラスコを2本用意し、1本目にはア
ルギン酸ナトリウム500mg,第3燐酸カルシウム500mgお
よびグルコース10gをメスフラスコに取り蒸留水を加え
て溶解し、100mlとした。2本目には、アルギン酸ナト
リウム500mgおよびグルコース10gをメスフラスコに取り
蒸留水を加え溶解し100mlとした。この2種類の試料の
耐糖能改善効果を比較すべくラットに投与した。ラット
はSD系雄性、体重約200gのものを1群6個体とし、計12
個を用いた。
Example 2 Two 100-ml volumetric flasks were prepared. First, 500 mg of sodium alginate, 500 mg of tricalcium phosphate and 10 g of glucose were placed in a volumetric flask and dissolved in distilled water to make 100 ml. For the second, 500 mg of sodium alginate and 10 g of glucose were placed in a volumetric flask and dissolved in distilled water to make 100 ml. Rats were administered to compare the glucose tolerance improving effects of these two types of samples. Rats with SD males and a body weight of about 200 g were divided into 6 groups, and a total of 12
Used.

まず、ラットを24時間絶食させ、上記2種類の試料を
体重100g当り1mlの割合で胃ゾンデにて強制投与した。
投与前,投与15分後,投与30分後および投与60分後の各
時点で尾静脈より血液30μを採血し、直ちにグルコー
スオキシダーゼ法で血糖値を測定した。結果を第3図に
示す。第3図に示されるごとく、アルギン酸ナトリウム
0.5%,第3燐酸カルシウム0.5%およびグルコース10%
を投与した群は、アルギン酸ナトリウム0.5%,および
グルコース10%を投与した群に比して、投与15分後の血
糖値は低値を示し、投与60分後ではやや高値を示した。
従って、アルギン酸ナトリウム0.5%,第3燐酸カルシ
ウム0.5%およびグルコース10%を投与した群は急激な
血糖値の上昇を抑え、ゆっくりと糖の吸収を行わせる、
即ち耐糖能を改善する効果が認められた。
First, rats were fasted for 24 hours, and the above-mentioned two kinds of samples were forcibly administered by a gastric sonde at a rate of 1 ml per 100 g of body weight.
Before administration, 15 minutes after administration, 30 minutes after administration, and 60 minutes after administration, 30 μm of blood was collected from the tail vein, and the blood glucose level was immediately measured by the glucose oxidase method. The results are shown in FIG. As shown in FIG. 3, sodium alginate
0.5%, tricalcium phosphate 0.5% and glucose 10%
The blood glucose level of the group administered with was lower than that of the group administered with 0.5% of sodium alginate and 10% of glucose at 15 minutes after administration, and slightly higher at 60 minutes after administration.
Therefore, a group administered with sodium alginate 0.5%, tricalcium phosphate 0.5% and glucose 10% suppresses a rapid rise in blood glucose level and allows slow sugar absorption.
That is, the effect of improving glucose tolerance was recognized.

実施例3 100ml容のメスフラスコを3本用意し、1本目にはア
ルギン酸ナトリウム500mgおよび炭酸カルシウム500mgを
メスフラスコに取り蒸留水を加えて溶解し、100mlとし
た。2本目には、アルギン酸ナトリウム500mgをメスフ
ラスコに取り蒸留水を加えて溶解し、100mlとした。ま
た、3本目には、アルギン酸ナトリウム500mgをメスフ
ラスコに取り蒸留水を加えて溶解し、100mlとしたの
ち、この溶液を100ml容ビーカーに移し、塩化カルシウ
ム500mgを加えゲルを形成させた。このゲルをミキサー
で粉砕し、被検液とした。この3種類の試料の耐糖能改
善効果を比較すべくラットに投与した。ラットはSD系雄
性、体重約200gのものを1群6個体とし、計24個を用い
た。
Example 3 Three 100-ml volumetric flasks were prepared. First, 500 mg of sodium alginate and 500 mg of calcium carbonate were placed in a volumetric flask and dissolved in distilled water to make 100 ml. For the second bottle, 500 mg of sodium alginate was placed in a volumetric flask and distilled water was added to dissolve it to make 100 ml. On the third line, 500 mg of sodium alginate was placed in a volumetric flask and dissolved by adding distilled water to make 100 ml. The solution was transferred to a 100 ml beaker, and 500 mg of calcium chloride was added to form a gel. This gel was crushed with a mixer to obtain a test liquid. Rats were administered to compare the glucose tolerance improving effects of these three samples. The rats were SD males and weighed approximately 200 g, and each group consisted of 6 individuals, and a total of 24 rats were used.

まず、ラットにストレプトゾトシンを体重100g当り55
mgの割合で尾静脈より注射して、糖尿病モデルラットを
作製し、2週間後実験に供した。ラットを24時間絶食さ
せ、上記3種類の試料を体重100g当り1mlの割合で胃ゾ
ンデにて強制投与し、その直後に10%グルコース溶液1m
lを胃ゾンデにて強制投与した。また、対照群には蒸留
水を体重100g当り1mlの割合で胃ゾンデにて強制投与
し、その直後に10%グルコース溶液1mlを胃ゾンデにて
強制投与した。投与前,投与15分後,投与30分後,投与
60分後および投与120分後の各時点で尾静脈より血液30m
lを採血し、直ちにグルコースオキシダーゼ法で血糖値
を測定した。結果を第4図に示す。第4図に示されるご
とく、アルギン酸ナトリウム0.5%,炭酸カルシウム0.5
%およびグルコース10%を投与した群では他の3群に比
して、投与15分後の血糖値は低値を示し、投与60分後で
はやや高値を示した。このような糖尿病ラットにおいて
もアルギン酸ナトリウム0.5%,炭酸カルシウム0.5%お
よびグルコース10%を投与した群では他の2群に比し
て、急激な血糖値の上昇を抑えゆっくりと糖の吸収を行
わせる、即ち、耐糖能を改善する効果が認められた。
First, rats are treated with streptozotocin at a dose of 55
A diabetic model rat was prepared by injecting at a ratio of mg from the tail vein, and used for the experiment after 2 weeks. The rats were fasted for 24 hours, and the above 3 kinds of samples were forcibly administered with a gastric sonde at a rate of 1 ml per 100 g of body weight, and immediately after that, 10% glucose solution 1 m
was forcibly administered with a gastric tube. In the control group, distilled water was forcibly administered with a gastric tube at a rate of 1 ml per 100 g of body weight, and immediately thereafter, 1 ml of a 10% glucose solution was forcibly administered with a gastric tube. Before administration, 15 minutes after administration, 30 minutes after administration, administration
Blood 30 m from the tail vein at 60 minutes and 120 minutes after administration
Blood was taken from l and the blood glucose level was immediately measured by the glucose oxidase method. The results are shown in FIG. As shown in FIG. 4, sodium alginate 0.5%, calcium carbonate 0.5
% And glucose 10%, the blood glucose level at 15 minutes after administration was lower and the blood glucose level was slightly higher at 60 minutes after administration than those of the other 3 groups. Even in such diabetic rats, the group to which sodium alginate 0.5%, calcium carbonate 0.5% and glucose 10% was administered suppresses the rapid increase in blood glucose level and allows the sugar to be absorbed slowly as compared with the other two groups. That is, the effect of improving glucose tolerance was recognized.

〔発明の効果〕〔The invention's effect〕

以上詳述したごとく、本発明の食品用組成物は、水溶
性食物繊維と中性領域で不溶性のカルシウム化合物を含
有することにより、摂取後胃内で胃酸と接触した際ゲル
を形成する。食物の胃内滞留時間は、成分によっても異
なるが、食物繊維においてはその粘度が高いほど胃内滞
留時間は長くなる。従って、本発明の食品用組成物を摂
取すれば、摂取時は低温でも粘度が低く嗜好性に優れて
いる上に以内ではゲル化し、胃内に長時間滞留するた
め、効果的に食欲を抑制することができる。しかも、糖
の吸収を遅延させるため、耐糖能をも改善する。さらに
は、本食品用組成物を摂取することにより、最近摂取の
不足が指摘されている食物繊維とカルシウムの栄養的な
補給も同時に行うことができる。また、カルシウムの吸
収を促進することが知られているカゼインホスホペプチ
ドと組み合わせることも容易であり、さらにカルシウム
の栄養的な補給効果を高めることができる。また、本発
明の食品用組成物は食品の加工時にpHが3.5以下になら
ないような工程を選べば、水溶性食物繊維と中性領域で
不溶性のカルシウム化合物の反応が生じないため、液
状,粉状,固形状などあらゆる食品の形態を選択するこ
とができ、かつ水溶性食物繊維と中性領域で不溶性のカ
ルシウム化合物はいずれも無味無臭に近いため、様々な
味付けが可能であり、本発明の食品用組成物を断続的に
摂取する場合、極めて好都合である。
As described above in detail, the food composition of the present invention contains a water-soluble dietary fiber and a calcium compound insoluble in the neutral region, and thus forms a gel upon contact with gastric acid in the stomach after ingestion. Although the gastric residence time of food varies depending on the components, the higher the viscosity of dietary fiber, the longer the gastric residence time. Therefore, when the food composition of the present invention is ingested, it has a low viscosity even at low temperature at the time of ingestion and is excellent in palatability, and gels within and stays in the stomach for a long time, thereby effectively suppressing the appetite. can do. Moreover, since glucose absorption is delayed, glucose tolerance is also improved. Further, by ingesting the present food composition, nutritional supplementation of dietary fiber and calcium, which has recently been pointed out to be insufficiently ingested, can be simultaneously performed. Further, it can be easily combined with casein phosphopeptide, which is known to promote calcium absorption, and the nutritional supplementation effect of calcium can be further enhanced. Further, the composition for food of the present invention, if the process is selected such that the pH does not become 3.5 or less during processing of the food, since the reaction between the water-soluble dietary fiber and the insoluble calcium compound in the neutral region does not occur, liquid, powder It is possible to select any form of food such as a solid form, a solid form, and since the water-soluble dietary fiber and the calcium compound insoluble in the neutral region are both tasteless and odorless, various flavoring is possible, It is extremely convenient when the food composition is ingested intermittently.

【図面の簡単な説明】[Brief description of the drawings]

第1図は各種食物繊維含有組成物溶液の温度−粘度相関
図、第2図は動物実験における投与30分後の胃内のグル
コースの残存量を示す図、第3図は正常なラットを用い
た試験における血糖値(ラット6匹の平均値)の変化を
示す図、第4図は糖尿病ラットを用いた試験における血
糖値(ラット6匹の平均値)の変化を示す図である。
FIG. 1 is a temperature-viscosity correlation diagram of various dietary fiber-containing composition solutions, FIG. 2 is a diagram showing a residual amount of glucose in the stomach 30 minutes after administration in an animal experiment, and FIG. 3 is a normal rat. Fig. 4 is a diagram showing changes in blood glucose level (average value of 6 rats) in the test, and Fig. 4 is a diagram showing changes in blood glucose level (average value of 6 rats) in the test using diabetic rats.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】(a)アルギン酸またはその塩と、(b)
炭酸カルシウム,第3燐酸カルシウム,卵殻カルシウ
ム,牛骨カルシウムおよび魚骨カルシウムの中から選ば
れた1種または2種以上のカルシウム化合物を含有する
組成物からなり、(a)アルギン酸またはその塩と
(b)カルシウム化合物中のカルシウムとの重量比が1:
0.5〜1:2であることを特徴とする食品用組成物。
1. (a) Alginic acid or a salt thereof, and (b)
A composition comprising one or more calcium compounds selected from calcium carbonate, tribasic calcium phosphate, egg shell calcium, bovine bone calcium and fish bone calcium, and (a) alginic acid or a salt thereof ( b) The weight ratio of calcium to the calcium compound is 1:
A composition for foods, which is 0.5 to 1: 2.
JP2125544A 1990-05-17 1990-05-17 Food composition Expired - Lifetime JP2673992B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2125544A JP2673992B2 (en) 1990-05-17 1990-05-17 Food composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2125544A JP2673992B2 (en) 1990-05-17 1990-05-17 Food composition

Publications (2)

Publication Number Publication Date
JPH0423968A JPH0423968A (en) 1992-01-28
JP2673992B2 true JP2673992B2 (en) 1997-11-05

Family

ID=14912827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2125544A Expired - Lifetime JP2673992B2 (en) 1990-05-17 1990-05-17 Food composition

Country Status (1)

Country Link
JP (1) JP2673992B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009524575A (en) * 2005-10-05 2009-07-02 エフエムシー バイオポリマー エイエス Gelling composition and method

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384087B1 (en) * 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
US7704979B2 (en) 2000-09-01 2010-04-27 The University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
WO2002096219A2 (en) 2001-05-31 2002-12-05 Abbott Laboratories Acid controlled viscosity fiber system and uses thereof
JP2004002320A (en) * 2002-03-04 2004-01-08 Medorekkusu:Kk Liquid matrix causing in-vivo phase transition and liquid oral preparation
EP1659883A1 (en) * 2003-09-03 2006-05-31 Unilever N.V. Satiety enhancing food compositions
RU2350123C2 (en) * 2003-09-03 2009-03-27 Юнилевер Н.В. Alimentary compositions increasing satiety
US9192573B2 (en) 2009-12-18 2015-11-24 Kaneka Corporation Treatment method using liquid food composition
KR101822076B1 (en) 2009-12-18 2018-01-25 가부시키가이샤 가네카 Liquid food composition
JP6124431B2 (en) * 2012-06-20 2017-05-10 シマダヤ株式会社 Noodles whose blood sugar level is difficult to rise after ingestion
JP6284264B2 (en) * 2013-11-06 2018-02-28 ユニテックフーズ株式会社 Novel gelling agent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
JPS6348210A (en) * 1986-08-19 1988-02-29 Freunt Ind Co Ltd Easily soluble granule
JPS63185339A (en) * 1986-09-01 1988-07-30 Terumo Corp Composition for food

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
JPS6348210A (en) * 1986-08-19 1988-02-29 Freunt Ind Co Ltd Easily soluble granule
JPS63185339A (en) * 1986-09-01 1988-07-30 Terumo Corp Composition for food

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009524575A (en) * 2005-10-05 2009-07-02 エフエムシー バイオポリマー エイエス Gelling composition and method

Also Published As

Publication number Publication date
JPH0423968A (en) 1992-01-28

Similar Documents

Publication Publication Date Title
CN101925307B (en) High energy liquid enteral nutritional composition
US8778410B2 (en) Oral or enteral composition useful for recovery of physical functions
US5716926A (en) Composition of pyruvate and protein and method for increasing protein concentration in a mammal
JP2673992B2 (en) Food composition
WO1988001477A1 (en) Food composition
JPH04503670A (en) Methods for preventing or treating calcium deficiency in cattle
JPS63287462A (en) Peptide nutrient agent
JP2002034592A (en) Method for producing protein-zinc readily absorbable in body
JP3393560B2 (en) Calcium absorption promoting composition containing water-soluble chitosan and additive for promoting calcium absorption
JP3720496B2 (en) Novel pectin and emulsion containing the same
EP1633211A1 (en) Hot liquid fiber product
JP2000325041A (en) Swallowing assisting food
KR20200016608A (en) The health food composition for regulating weight
JP2010083858A (en) Nutrient suitable for improvement of symptom or nutritional condition of cancer patient
JP4484254B2 (en) Amino acid composition
JP2000050819A (en) Rice gruel
JP5527986B2 (en) Pharmaceutical composition
JP2000189109A (en) Liquid food
US20040048925A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
JPH07147935A (en) Food for diet-diabetes
US20040220266A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
JP3165743B2 (en) Liquid food
JPH0364098B2 (en)
JPH09132531A (en) Composition for additive to liquid food and liquid food
JPH0515339A (en) Protein-like composition, nourishing medicine for serious stress and nourishing medicine for hepatic disease

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090718

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100718

Year of fee payment: 13

EXPY Cancellation because of completion of term